Financial results - GENERAL BIOTECH SRL

Financial Summary - General Biotech Srl
Unique identification code: 30356876
Registration number: J40/7342/2012
Nace: 4221
Sales - Ron
2.209.704
Net Profit - Ron
62.554
Employee
27
The most important financial indicators for the company General Biotech Srl - Unique Identification Number 30356876: sales in 2023 was 2.209.704 euro, registering a net profit of 62.554 euro and having an average number of 27 employees. Firma isi desfasoara activitatea in domeniul Lucrari de constructii a proiectelor utilitare pentru fluide having the NACE code 4221.

Sales, Profit, Employees, Debts, Capitals, Financial Results - General Biotech Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 687 434.393 742.453 1.555.061 964.459 774.535 1.867.250 1.371.739 1.324.477 2.209.704
Total Income - EUR 687 434.448 1.015.024 1.323.987 978.138 1.124.467 1.640.606 1.599.205 1.523.378 1.965.218
Total Expenses - EUR 7.969 338.525 980.339 1.096.192 762.778 1.012.942 1.579.652 1.538.073 1.473.904 1.890.561
Gross Profit/Loss - EUR -7.281 95.923 34.685 227.795 215.360 111.525 60.954 61.131 49.474 74.658
Net Profit/Loss - EUR -7.281 80.957 27.856 185.072 177.595 103.748 47.318 48.001 39.974 62.554
Employees 0 1 2 5 11 11 14 17 21 27
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 67.3%, from 1.324.477 euro in the year 2022, to 2.209.704 euro in 2023. The Net Profit increased by 22.701 euro, from 39.974 euro in 2022, to 62.554 in the last year.

Check the financial reports for the company - General Biotech Srl

Rating financiar

Financial Rating -
General Biotech Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
General Biotech Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
General Biotech Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
General Biotech Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - General Biotech Srl - CUI 30356876

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 559 1.710 29.426 119.372 96.226 71.355 44.831 25.045 11.513 14.684
Current Assets 156.437 235.977 1.057.719 1.049.918 463.891 671.371 822.744 1.260.584 1.012.296 1.243.887
Inventories 0 0 242.918 33.492 24.623 372.013 161.316 402.830 592.710 343.348
Receivables 149.849 190.298 792.675 1.009.356 426.372 292.573 648.135 809.256 312.804 846.941
Cash 6.588 45.679 22.125 7.070 8.602 6.784 13.293 48.498 106.781 53.598
Shareholders Funds -1.595 79.349 32.256 187.520 177.641 147.718 61.125 51.324 49.628 82.877
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 169.260 158.828 1.057.141 985.015 384.567 600.151 816.685 1.247.166 981.773 1.181.345
Income in Advance 0 0 315.822 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4221 - 4221"
CAEN Financial Year 4221
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.243.887 euro in 2023 which includes Inventories of 343.348 euro, Receivables of 846.941 euro and cash availability of 53.598 euro.
The company's Equity was valued at 82.877 euro, while total Liabilities amounted to 1.181.345 euro. Equity increased by 33.399 euro, from 49.628 euro in 2022, to 82.877 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - General Biotech Srl

Comments - General Biotech Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.